Search Results
Feb 17, 2026, 10:02 ET The Center for Cancer and Blood Disorders Revolutionizes the Delivery of CAR-T Cancer Treatments for Texas Patients
Practices in Texas to Deliver a CAR-T Therapy Outside a Hospital or Academic CenterIn Collaboration with Local Community Hospitals, Dr. Rohan Gupta, is Treating a 62-year-old Bowie Man with CAR-TNew State Law Recently Expanded Patient Access to CAR-TFORT
More news about: The Center for Cancer and Blood Disorders
Feb 17, 2026, 10:00 ET Toyota's All-Electric Lineup Gains Rugged, Powerful New bZ Woodland SUV
Woodland has a Wi-Fi Connect trial (30 days or up to 3GB after activation) that offers 4G connectivity for up to five devices – turning the bZ into an AT&T Hotspot.Adding to the already robust offering of audio playback ability with HD Radio, USB data and a SiriusXM® 3-month trial subscription,
More news about: Toyota Motor North America
Feb 17, 2026, 09:37 ET Molex Launches Impress Co-Packaged Copper Solutions, Scaling Near-ASIC Connectivity Innovations to Meet Next-Generation Data Rate Demands
transmissions caused by the rise in hyperscale data centers, generative AI, Large Language Models (LLMs) and cloud computing, along with the jump from 1.6T to 3.2T networking.Product AvailabilityMolex Impress Co-Packaged Copper Solutions are available now for applications requiring data
More news about: Molex Incorporated
Feb 17, 2026, 09:00 ET Metabolon's Metabolomics Platform Enables Largest Metabolomic Analysis to Date in CAR T-Cell Therapy, Revealing New Insights into Severe Neurotoxicity
the context of CAR T-cell therapy. Leveraging Metabolon's untargeted Global Discovery Panel, Kite researchers analyzed more than 3,800 longitudinal serum and plasma samples—and a rare set of cerebrospinal fluid (CSF) samples—from patients treated with the FDA-approved anti-CD19 CAR T-cell therapies axicabtagene
More news about: Metabolon, Inc.
Feb 17, 2026, 09:00 ET Metabolon's Metabolomics Platform Enables Largest Metabolomic Analysis to Date in CAR T-Cell Therapy, Revealing New Insights into Severe Neurotoxicity
the context of CAR T-cell therapy. Leveraging Metabolon's untargeted Global Discovery Panel, Kite researchers analyzed more than 3,800 longitudinal serum and plasma samples—and a rare set of cerebrospinal fluid (CSF) samples—from patients treated with the FDA-approved anti-CD19 CAR T-cell therapies axicabtagene
More news about: Metabolon, Inc.
Feb 17, 2026, 09:00 ET HABRI and Virbac Join Forces in Support of the Human-Animal Bond
https://pmc.ncbi.nlm.nih.gov/articles/PMC10006577/ iii Thorpe, R. J., Simonsick, E. M., Brach, J. S., Ayonayon, H., Satterfield, S., Harris, T. B., ... & Health, Aging and Body Composition Study. (2006). Dog ownership, walking behavior, and maintained mobility in late life. Journal of the
More news about: Human Animal Bond Research Institute (HABRI)
Feb 17, 2026, 08:59 ET JYM Supplement Science Launches Creatine+, Its First-Ever Standalone Creatine Formula
supported forms of creatine: creatine monohydrate and NO3-T® creatine nitrate. Each serving delivers a full 5 grams of creatine, including 4 grams of creatine monohydrate and 1 gram of NO3-T® creatine nitrate.In addition to contributing creatine, NO3-T® provides 500mg of nitrates, helping to enhance blood
More news about: JYM Supplement Science
Feb 17, 2026, 08:38 ET One Battle After Another, Sinners, Frankenstein Motion Picture Winners at the 13TH Annual Make-Up Artists & Hair Stylists Guild Awards
Seasons), Nadine Bhabha (Heated Rivalry), Madeleine McGraw (Black Phone 2), Lauren Holt (I Love LA), Brandon T. Jackson (Percy Jackson: Sea of Monsters), Affion Crockett (The Hip Hop Story), Lisa Lisa (Can You Feel the Beat: The
More news about: Make-Up Artists & Hair Stylists Guild (MUAHS, IATSE Local 706)
Feb 17, 2026, 08:35 ET The American Diabetes Association Announces 2026 Pathway to Stop Diabetes Grant Recipients
a novel T cell therapy to enhance thermogenic function of adipose tissue, seeks to harness targeted cellular therapy and CRISPR technology to offer durable, preventative interventions against obesity-induced diabetes."This award will enable us to pursue a novel type of living T cell-based
More news about: American Diabetes Association
Feb 17, 2026, 08:15 ET American Lithium Minerals, Inc. (OTC: AMLM) Reports Fiscal Q1 2026 Results and Provides Update on Potentially Largest Lithium and Gold Discoveries in North America
project has 27 Exploitation Licenses. Previously there was 9,000m of mostly shallow (<150m) drilling with hits such as 50m @ 1.2% Cu and 10m @ 2.4g/t Au. Cheryl Creek Gold Project – Yukon, Canada The company operates a turn-key gold mining project at Cheryl Creek, located
More news about: American Lithium Minerals, Inc
Feb 17, 2026, 08:03 ET Mesh Partners with Adyen to Accelerate the Scale of its European and U.K. Operations
LONDON, Feb. 17, 2026 /PRNewswire/ -- Mesh Payments ("Mesh"), the leading travel and expense (T&E) management platform for modern enterprises, today announced a strategic partnership with Adyen, the global financial technology platform of choice
More news about: Mesh Payments
Feb 17, 2026, 08:00 ET Superior HealthPlan Publishes 2025 Community Investment Report
Introducing Strong Youth Strong Communities. Teamed up with the Pro Football Hall of Fame to host 1,000 students at AT&T Stadium in Arlington, helping them build skills to address the mental health challenges they may be facing.
More news about: Superior HealthPlan
Feb 17, 2026, 08:00 ET Pinpoint Predictive Secures Ohio and Georgia Approvals, Expanding Rating Model Approvals to Nine States
LinkedIn.Media ContactBlaire SwayzeDirector of InsurTech Comms & PRT Palmer [email protected]
More news about: Pinpoint Predictive
Feb 17, 2026, 08:00 ET FDA approves RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) as the only EGFR-targeted therapy that can be administered once a month
LAZCLUZE® (marketed as LECLAZA in South Korea). LAZCLUZE® is an oral, third-generation, brain-penetrant EGFR TKI that targets both the T790M mutation and activating EGFR mutations while sparing wild-type EGFR. An analysis of the efficacy and safety of LAZCLUZE® from the Phase
More news about: Johnson & Johnson
Feb 17, 2026, 07:45 ET TuHURA Files Investigational New Drug Application for TBS-2025 in the Treatment of Blood-Related Cancers
acquired by the Company in its acquisition by merger with Kineta Inc. on June 30, 2025. VISTA is a novel checkpoint expressed on quiescent (resting) T cells and highly expressed on myeloid cells. Unlike the expression of VISTA on solid tumor cancers, its role is well established in hematological malignancies.
More news about: TuHURA Biosciences, Inc.
Feb 17, 2026, 07:20 ET PIPE BEVELING CUTTER BLADES PRECISION GROUND FOR SUPERIOR PERFORMANCE
MILLHOG® Cutter Blades are precision ground from T-15 tool steel before being formed into any angle of prep including 37.5o, J-prep, and compound bevels and then TiN (titanium nitride) coated
More news about: ESCO Tool
Feb 17, 2026, 07:00 ET AT&T to Webcast Fireside Chats with CFO and COO at Upcoming Investor Conferences
AT&T (NYSE:T) will webcast a series of fireside chats with Pascal Desroches, chief financial officer, AT&T, and Jeff McElfresh, chief operating officer, AT&T. Upcoming investor conference schedulePascal
More news about: AT&T
Feb 17, 2026, 07:00 ET Luca intersects 136 metres of 1.6 g/t Gold, 77 g/t Silver, 0.9% copper and 1.6% zinc at largo Norte Zone, Campo Morado Mine
135.7m of 1.58 g/t Au, 77.10 g/t Ag, 0.88% Cu, 0.40% Pb and 1.61% Zn from 87.7m Including 101.5m of 1.92 g/t Au, 98.59 g/t Ag, 0.88% Cu, 0.52% Pb and 2.14% Zn from 121.9m with a high grade section of 16.0m of 3.20 g/t Au, 191.84 g/t Ag, 0.99% Cu, 1.29% Pb and 5.03% Zn
More news about: Luca Mining Corp.
Feb 17, 2026, 07:00 ET Thesis Gold Rebrands to Thesis Gold & Silver
("AuEq") ounces in the Measured and Indicated category ("M&I") at an average grade of 1.21 grams per tonne ("g/t"), including 97.89 million ounces of silver at 25.9 g/t. The PFS outlines average annual production of approximately 187,000 AuEq ounces, including 3.5 million ounces of
More news about: Thesis Gold Inc.
Feb 17, 2026, 07:00 ET Portal Diabetes Gets FDA Breakthrough for Pump, Starts Insulin Study
Two steps toward bringing a functional cure to T1DWESTFIELD, Ind., Feb. 17, 2026 /PRNewswire/ -- Today, Portal Diabetes, Inc. ("Portal") announced its receipt of the Breakthrough Device Designation by the Food and Drug
More news about: Portal Diabetes, Inc.
Feb 17, 2026, 07:00 ET Nektar Therapeutics Announces Research Collaboration with UCSF and Dr. Stephen Hauser for NKTR-0165, a Tumor Necrosis Factor Receptor 2 (TNFR2) Antibody, in Multiple Sclerosis
gatekeeper of inflammation and its absence or deficit is associated with a broad range of autoimmune diseases. TNFR2 is highly expressed on regulatory T cells (Tregs), endothelial cells, and neuronal cells, many of which are involved in the pathogenesis of MS.1"We are privileged to partner
More news about: Nektar Therapeutics
Feb 17, 2026, 06:59 ET Q32 Bio Announces $10.5 Million Registered Direct Offering
treatment of alopecia areata in an ongoing Phase 2 program. The IL-7 and TSLP pathways have been genetically and biologically implicated in driving several T cell-mediated pathological processes in numerous autoimmune diseases.1National Alopecia Areata FoundationForward-Looking StatementsThis
More news about: Q32 Bio
Feb 17, 2026, 06:44 ET Medtronic announces first surgery with Hugo™ robotic-assisted surgery system in the U.S. performed at Cleveland Clinic
medtronic.com/hugoishere.†Compared to open surgery.Fitch K, Engel T, Bochner A. Cost differences between open and minimally invasive surgery. Managed Care. 2015;24(9):40–48.Tiwari MM, Reynoso JF, High R,
More news about: Medtronic plc
Feb 17, 2026, 06:30 ET GoldMining Updates Mineral Resource Estimate with Inclusion of Antimony at its Crucero Gold Project, Peru
previous MRE (Effective Date December 20, 2017) comprised 30.6 Mt at 1.0 g/t Au for 0.99 Moz Au Indicated resources, and 35.8 Mt at 1.0 g/t Au for 1.1 Moz Au Inferred resources, at a gold price of $1,500 per ounce and a 0.40 g/t Au cut-off grade.Updated Crucero Project Mineral Resource
More news about: GoldMining Inc.
Feb 17, 2026, 06:30 ET PermRock Royalty Trust Declares Monthly Cash Distribution
underlying the Trust totaled $0.95 million for the current month, an increase of $0.04 million from the prior month's distribution period. T2S Permian Acquisition II LLC ("T2S") informed the Trust that this increase was primarily due to an increase in oil sales volumes.Natural gas cash receipts for the
More news about: PermRock Royalty Trust